Loading…
Ajanta Pharma (AJANTPHARM)₹3,344+0.17%Pharmaceuticals
At the end of the Sep 2026 quarter, Ajanta Pharma's shareholders were: promoters 63.42%, FIIs 7.68%, DIIs 21.95%, public 6.95%. Promoter holding is down 0.02 percentage points from 63.44% a quarter earlier. FII holding is down 0.91 percentage points from 8.59% a year earlier. 22.46% of promoter shares were pledged. It had 61,930 shareholders.
As of · Company filings (shareholding pattern)
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 66.17% | 66.17% | 66.22% | 66.21% | 66.21% | 66.21% | 66.21% | 66.20% | 66.20% | 66.20% | 63.44% | 63.42% |
| FIIs | 9.17% | 8.60% | 8.42% | 9.17% | 9.32% | 8.92% | 8.92% | 8.59% | 8.03% | 8.32% | 7.74% | 7.68% |
| DIIs | 16.68% | 17.49% | 17.42% | 17.10% | 17.03% | 17.49% | 17.51% | 17.91% | 18.59% | 18.37% | 21.81% | 21.95% |
| Government | 0.00% | 0.00% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.00% | 0.00% |
| Public | 7.98% | 7.74% | 7.93% | 7.51% | 7.43% | 7.37% | 7.35% | 7.29% | 7.17% | 7.10% | 7.01% | 6.95% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 22.46% |
| Number of shareholders | 54,357 | 55,494 | 70,324 | 64,322 | 66,904 | 70,835 | 68,890 | 67,793 | 65,416 | 67,963 | 65,303 | 61,930 |
| Holder | Category | Sep 2026 | Change (pp) |
|---|---|---|---|
| Rajesh M Agrawal, trustee Rajesh Agrawal Trust | Promoter | 14.46% | 0.00 |
| Yogesh M Agrawal, trustee Yogesh Agrawal Trust | Promoter | 14.43% | 0.00 |
| Aayush M Agrawal, trustee Aayush Agrawal Trust | Promoter | 11.30% | −0.01 |
| Ravi P Agrawal, trustee Ravi Agrawal Trust | Promoter | 10.28% | 0.00 |
| Gabs Investments Pvt Ltd | Promoter | 10.09% | −0.01 |
| Kotak Flexicap Fund | DII | 3.21% | −0.06 |
| Uti-Flexi Cap Fund | DII | 2.96% | −0.14 |
| Nippon Life India Trustee Ltd-A/C Nippon India Small Cap Fund | DII | 2.80% | +0.01 |
| Ganga Exports being represented by Yogesh Agrawal, Rajesh Agrawal & Ravi Agrawal | Promoter | 2.67% | 0.00 |
| Aditya Birla Sun Life Mutual Fund - Aditya Birla Sun Life Midcap Fund | DII | 2.24% | New |
| Tata Aia Life Insurance Co Ltd-Whole Life Mid Cap Equity Fund-Ulif 009 04/01/07 Wle 110 | DII | 1.89% | +0.01 |
| Canara Robeco Mutual Fund A/C Canara Robeco Small Cap Fund | DII | 1.41% | −0.06 |
| Hdfc Large And Mid Cap Fund | DII | 1.02% | −0.13 |
| Ravi P Agrawal | Promoter | 0.23% | 0.00 |
| Aayush M Agrawal | Promoter | 0.02% | 0.00 |
| Aditya Birla Sun Life Trustee Private Limited A/C Aditya Birla Sun Life Midcap Fund | DII | Exited | — |
Promoters held 63.42% of Ajanta Pharma at the end of the Sep 2026 quarter, down 2.78 percentage points from 66.20% a year earlier.
In the Sep 2026 quarter, foreign institutional investors (FIIs) held 7.68% (down 0.06 percentage points from 7.74% a quarter earlier) and domestic institutions (DIIs) held 21.95% (up 0.14 percentage points from 21.81% a quarter earlier).
Yes. 22.46% of promoter shares were pledged at the end of the Sep 2026 quarter.
Ajanta Pharma had 61,930 shareholders at the end of the Sep 2026 quarter, against 67,793 a year earlier.
Kotak Flexicap Fund (DII) held 3.21% at the end of the Sep 2026 quarter, the largest named holding outside the promoter group.